Nipro Corp
F:5FA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nipro Corp
F:5FA
|
JP |
Intrinsic Value
The intrinsic value of 
Nipro Corp (5FA) under the Base Case is 7 EUR per share.
Compared with the current market price of 7.45 EUR, the stock appears
Overvalued by 6% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Nipro Does
Nipro Corp is a Japanese healthcare company that makes products used in hospitals, clinics, pharmacies, and drug manufacturing. Its core business includes medical devices such as dialysis equipment, infusion and injection products, and disposable supplies, along with pharmaceutical packaging and glass products for medicines. It also sells materials and equipment used in the production and handling of drugs.
- Headquarters
- Japan JP
- Employees
- 39 168
- IPO date
- Feb 1, 1987
Revenue & Expenses Breakdown
Nipro Corp
Earnings Waterfall
Nipro Corp
The intrinsic value for Nipro Corp (5FA) under the Base Case is 7 EUR.
Compared with the current market price of 7.45 EUR, the stock appears Overvalued by 6% .